2015 confirmed a significant recent trend in the flagship WHO Model List of Essential Medicines with groundbreaking new treatments for hepatitis C and a varietyof cancers included in the list despite their high prices. The list also included five new medicines for multidrug resistant tuberculosis (TB), among other updates.Traditionally considered a tool for developing countries to use as a guide for national medicines selection, the WHO Essential Medicines List is increasingly seen as a tool to increase access globally.
0 Comments